Cagrilintide — ≥98% Research Peptide

Long-Acting Amylin Analog — Companion to Semaglutide

A novel long-acting amylin analog (Novo Nordisk) being studied with semaglutide as 'CagriSema' — one of the most anticipated next-generation obesity peptides.

Research Applications & Benefits

Doses Used in Published Studies

Literature values for laboratory reference only — not dosing guidance.

No verified dose data from published studies is listed for Cagrilintide yet.

Laboratory Handling

Product Specifications

Compound
Cagrilintide
CAS Number
1415456-99-3
Molecular Weight
3789.43 g/mol
HPLC Purity Specification
≥98%
Category
GLP-1 & Metabolic
Starting Price
$99.00 USD
Country of Origin
United States
Shipping
Cold-chain insulated packaging, fast domestic delivery
Payment
Card, ACH, and cryptocurrency (10% discount)

Quality & Verification

Cagrilintide carries the purity specification shown above. Where a lot-specific CertikLabs Certificate of Analysis is available, the product page links its HPLC purity, LC-MS identity, and concentration results.

Frequently Asked Questions

Is Cagrilintide suitable for human consumption?

No. Cagrilintide is sold strictly for in-vitro laboratory research. It is not a drug, supplement, cosmetic, or food product and must not be administered to humans or animals.

What purity is Cagrilintide?

Cagrilintide carries a ≥98% HPLC purity specification. Check the product page for an available lot report.

How is Cagrilintide shipped and stored?

Vials are shipped lyophilized in temperature-controlled packaging. Store unopened lyophilized peptide at −20°C; once reconstituted with bacteriostatic water, store at 2–8°C and use within 28 days.

Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.